Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases
- PMID: 26863267
- PMCID: PMC4838490
- DOI: 10.1097/MIB.0000000000000714
Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases
Abstract
Pathogenesis of the inflammatory bowel diseases (IBDs), such as ulcerative colitis (UC) and Crohn's disease (CD), involve proinflammatory changes within the microbiota, chronic immune-mediated inflammatory responses, and epithelial dysfunction. Converging data from genome-wide association studies, mouse models of IBD, and clinical trials indicate that cytokines are key effectors of both normal homeostasis and chronic inflammation in the gut. Yet many questions remain concerning the role of specific cytokines in different IBDs within distinct regions of the gut, and regarding cellular mechanisms of action. In this article, we review current and emerging concepts concerning the role of cytokines in IBD with a focus on immune regulation, T cell subsets, and potential clinical applications.
References
-
- Baumgart DC, Sandborn WJ. Crohn's disease. Lancet. 2012;380:1590–1605. doi:10.1016/S0140-6736(12)60026-9. - PubMed
-
- Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380:1606–1619. doi:10.1016/S0140-6736(12)60150-0. - PubMed
-
- Molodecky NA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54. e42; quiz e30, doi:10.1053/j.gastro.2011.10.001. - PubMed
-
- Kaplan GG. The global burden of IBD: from 2015 to 2025. Nature reviews. Gastroenterology & hepatology. 2015 doi:10.1038/nrgastro.2015.150. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
